Treatment of West Nile virus encephalitis with intravenous immunoglobulin.
作者信息
Shimoni Z, Niven M J, Pitlick S, Bulvik S
出版信息
Emerg Infect Dis. 2001 Jul-Aug;7(4):759. doi: 10.3201/eid0704.010432.
Abstract
摘要
相似文献
1
Treatment of West Nile virus encephalitis with intravenous immunoglobulin.
Emerg Infect Dis. 2001 Jul-Aug;7(4):759. doi: 10.3201/eid0704.010432.
2
West Nile encephalitis in Israel, 1999: the New York connection.
Emerg Infect Dis. 2001 Jul-Aug;7(4):659-61. doi: 10.3201/eid0704.010410.
3
Human immunoglobulin as a treatment for West Nile virus infection.
J Infect Dis. 2003 Jul 1;188(1):1-4. doi: 10.1086/376871. Epub 2003 Jun 23.
4
The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis.
Clin Infect Dis. 2003 Sep 15;37(6):e88-90. doi: 10.1086/377172. Epub 2003 Aug 27.
5
West Nile virus encephalitis acquired via liver transplantation and clinical response to intravenous immunoglobulin: case report and review of the literature.
Transpl Infect Dis. 2011 Jun;13(3):312-7. doi: 10.1111/j.1399-3062.2010.00595.x. Epub 2011 Jan 16.
6
[Patient with West Nile fever in the Netherlands].
Ned Tijdschr Geneeskd. 2001 Oct 27;145(43):2084-6.
7
Equine West Nile encephalitis, United States.
Emerg Infect Dis. 2001 Jul-Aug;7(4):665-9. doi: 10.3201/eid0704.010412.
8
[West Nile virus].
Nihon Rinsho. 2010 Jun;68 Suppl 6:339-41.
9
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically.
Clin Infect Dis. 2010 Aug 15;51(4):e34-7. doi: 10.1086/655146.
10
Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection.
BMC Infect Dis. 2009 Feb 17;9:18. doi: 10.1186/1471-2334-9-18.
引用本文的文献
1
Convalescent plasma - An insight into a novel treatment of covid-19 ICU patients.
Transfus Apher Sci. 2022 Dec;61(6):103497. doi: 10.1016/j.transci.2022.103497. Epub 2022 Jul 1.
2
Engineering the Single Domain Antibodies Targeting Receptor Binding Motifs Within the Domain III of West Nile Virus Envelope Glycoprotein.
Front Microbiol. 2022 Apr 1;13:801466. doi: 10.3389/fmicb.2022.801466. eCollection 2022.
3
The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus Disease.
Front Immunol. 2021 Sep 6;12:717425. doi: 10.3389/fimmu.2021.717425. eCollection 2021.
4
The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections.
Life (Basel). 2021 Jul 23;11(8):734. doi: 10.3390/life11080734.
5
Clinical Outcomes of Japanese Encephalitis after Combination Treatment of Immunoglobulin, Ribavirin, and Interferon-α2b.
J Clin Neurol. 2021 Jul;17(3):428-434. doi: 10.3988/jcn.2021.17.3.428.
6
Qualifying coronavirus disease 2019 convalescent plasma donors in Israel.
Vox Sang. 2022 Feb;117(2):185-192. doi: 10.1111/vox.13162. Epub 2021 Jun 14.
7
Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome.
Int Immunopharmacol. 2021 Apr;93:107239. doi: 10.1016/j.intimp.2020.107239. Epub 2020 Dec 2.
8
Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic.
Risk Manag Healthc Policy. 2020 Nov 23;13:2707-2728. doi: 10.2147/RMHP.S281388. eCollection 2020.
9
Why will it never be known if convalescent plasma is effective for COVID-19.
J Transl Autoimmun. 2020;3:100069. doi: 10.1016/j.jtauto.2020.100069. Epub 2020 Nov 4.
10
Convalescent plasma in Covid-19: Possible mechanisms of action.
Autoimmun Rev. 2020 Jul;19(7):102554. doi: 10.1016/j.autrev.2020.102554. Epub 2020 May 5.
Zotero 插件